Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

R&D Consortium to Develop Optical Sorting of Stem Cells

Published: Tuesday, December 17, 2013
Last Updated: Tuesday, December 17, 2013
Bookmark and Share
Dolomite is collaborating with European technology leaders over a two year publicly funded consortium.

Danish project partners OptoRobotix (R&D performing SME) and Bioneer (technological service partner) and Dolomite will jointly develop a cutting edge stem cell handling technology. As the market leader in microfluidic design, Dolomite will exploit its latest offerings to transform from concept to biotech device. The collaboration recognizes Dolomite’s proven track of Productizing Science®, its unique business philosophy. 

Named OPTISORT (E! 7790 OPTISORT), the platform is expected to provide ‘Sorting and analysis platform for fragile mammalian cells using novel combination of optical and droplet technology’. The areas of stem cell biology and mammalian cell based protein manufacturing are developing fast. The ability for gentle cell sorting technologies and methods is expected to enable customers exploit unprecedented applications of cell biology in technology. The Consortium combines novel optical and droplet technology to create a commercial attractive platform. The collaboration has awarded close to 1 million Euros with a view to benefit the biotechnology, pharmaceutical and molecular biology industry. 

The collaboration is made possible by the Eurostars Programme – a European Joint Programme dedicated to the R&D performing SMEs, co-funded by the European Communities and 33 EUREKA member countries. Eurostars aims to stimulate SMEs with a promising potential for international collaborative research and innovation, enabling the route to international markets. Eurostars, the first European funding programme dedicated to innovation driven SMEs highlights their importance as essential sources of growth, employment, entrepreneurial skills, innovation and economic and social cohesion. On average, a Eurostars project has 3 to 4 Participants, 2-3 Countries, 29 Months duration, and €1.4M R&D budget. Of a total of 9807 applicants, 613 Projects were successfully funded with a total budget of €878M (€390M Estimated Public Funding).


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
The Mending Tissue - Cellular Instructions for Tissue Repair
NUS-led collaborative study identifies universal mechanism that explains how tissue shape regulates physiological processes such as wound healing and embryo development.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
iPS Cells Discover Drug Target for Muscle Disease
Researchers have designed a model that reprograms fibroblasts to the early stages of their differentiation into intact muscle cells in a step towards a therapeutic for Duchenne muscular dystrophy.
Engineered Hot Fat Implants Reduce Weight Gain
Scientists at UC Berkeley have developed a novel way to engineer the growth and expansion of energy-burning “good” fat, and then found that this fat helped reduce weight gain and lower blood glucose levels in mice.
Transplanted Stem Cells Can Benefit Retinal Disease Sufferers
Tests on animal models show that MSCs secrete growth factors that suppress causes of diabetic retinopathy and macular degeneration.
MRI Scanners Can Steer Therapeutics to Specific Target Sites
Scientists from the University of Sheffield have discovered MRI scanners, normally used to produce images, can steer cell-based, tumour busting therapies to specific target sites in the body.
Team Finds Early Inflammatory Response Paralyzes T Cells
Findings could have enormous implications for immunotherapy, autoimmune disorders, transplants and other aspects of immunity.
Early Detection of Lung Cancer
The University of Manchester has signed a collaboration agreement with Abcodia to perform proteomics studies on a cohort of non-small cell lung cancer cases from the UKCTOCS biobank, with the aim of discovering new blood-based biomarkers for earlier detection of the disease.
Researchers Identify Drug Candidate for Skin, Hair Regeneration
Formerly undiscovered role of protein may lead to the development of new medications that stimulate hair and skin regeneration in trauma or burn victims.
Basis for New Treatment Options for a Fatal Leukemia in Children Revealed
Detailed molecular analyses allow new insights into the function of tumour cells and options for new treatments.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!